Skip to main content

Table 1 Characteristics of the Eyes within the vitreoretinal interface pathologies group

From: Identification of epiretinal proliferation in various retinal diseases and vitreoretinal interface disorders

  Lamellar macular hole Full-thickness macular hole Epiretinal membrane Post-macular peeling All eyes
N, eyes 12 (38.7%) 4 (12.9%) 8 (25.8%) 7 (22.6%) 31 (100.0%)
Clinical data
 Visual acuity, LogMAR (Snellen equivalent) 0.50 ± 0.54 (20/63) 0.52 ± 0.30 (20/66) 0.47 ± 0.63 (20/59) 0.24 ± 0.19 (20/34) 0.43 ± 0.48 (20/53)
 Phakic lens status 3 (25.0%) 0 (0%) 1 (12.5%) 0 (0%) 4 (12.9%)
 Glaucoma 3 (25.0%) 1 (25.0%) 3 (37.5%) 3 (42.9%) 10 (32.3%)
 Retinal tear 0 (0%) 0 (0%) 0 (0%) 3 (42.9%) 3 (9.7%)
 Retinal detachment 1 (8.3%) 1 (25.0%) 2 (25.0%) 1 (14.3%) 5 (16.1%)
SD-OCT features
 Macular PVDa 8/10 (80.0%) 1/1 (100.0%) 6/6 (100%) 15/17 (88.2%)
 ERM 8 (66.7%) 1 (25.0%) 8 (100.0%) 3 (42.9%) 20 (64.5%)
 ELM disruptionb 8 (66.7%) 2 (25.0%) 4 (57.1%) 14/27 (51.9%)
 EZ disruptionb 9 (75.0%) 2 (25.0%) 4 (57.1%) 15/27 (55.6%)
 N, ETDRS quadrants 4.6 ± 1.7 4.0 ± 2.7 2.6 ± 2.0 2.7 ± 2.4 3.6 ± 2.2
  1. N number, SD-OCT spectral-domain optical coherence tomography, PVD posterior vitreous detachment, ERM epiretinal membrane, ELM external limiting membrane, EZ ellipsoidal zone, ETDRS early treatment diabetic retinopathy study
  2. aVitrectomized eyes are not included
  3. bFull-thickness macular holes are not included